Prediction of coronary atherosclerosis in endurance athletes by Kristian Berge

Beautiful presentation by Nur Sourour on the association between NT-proBNP and incident ventricular arrhythmias 🌟

Congratulations Kristian Berge 🌟

@stiftkgj Annual Symposium about «Internationalization in Research» was amazing with talks from Nobel laureate Edvard Ingjald Moser and my own mentor scottdavidsolomon who travelled from Harvard Medical School to share his experience of hosting 107 (!!) international scholars 🙏🏻

In 13,900 HF-free individuals, we identified 37 proteins consistently associated with incident HF independent of traditional risk factors. The majority with higher risk, but also a few with lower risk! NT-proBNP was (by far) the strongest, followed by SVEP1, WFDC2 and ANGPT2

We now have RCT evidence for #ARNI in all 4 corners of the LVEF-by-acuity spectra in HF ◻️ #PARADIGM #PARAGON #PIONEER #PARAGLIDE We summarize the data showing striking consistency in effects up to normal EF, irresp of acuity! Carolyn Lam JACC Journals sciencedirect.com/science/authSh…

In the PRADA trial, there was a marked difference in incidence of mild, asymptomatic CTRCD when defined by cTnT vs cTnI and sex-specific vs sex-neutral 99th percentiles URLs during adjuvant breast cancer therapy Albulena Mecinaj GeetaGulati Torbjørn Omland K.G. Jebsen Center for Cardiac Biomarkers @Ahus_no

Can #troponin be used to rule out cardiac abnormalities after #COVID19 ? In this study led by PhD-student Tarjei Øvrebotten 💫, we measured hs-TnT during hospitalization, after 3 and 12 months and associated that with changes in #echo and #CMR link.springer.com/article/10.118…

Today Nur Sourour defended her thesis brilliantly from tough and insightful opposition /BBQ by #HeikkiHuikuri and #OleChristianMjølstad 🔥 I am so proud! CONGRATULATIONS 🍾 K.G. Jebsen Center for Cardiac Biomarkers @Ahus_no UiO - Det medisinske fakultet

We are thrilled to announce that our group leader and mentor Torbjørn Omland Torbjørn Omland has been appointed member of The Norwegian Academy of Science Det Norske Videnskaps-Akademi ⭐️ 📷 DNVA/Thomas B. Eckhoff

🔥off the press in EJHF European Society of Cardiology Journals EJHF Editor-in-Chief Changes in #6MWT in HFrEF during uptitration of #GDMT is a predictor of survival independent of changes in NT-proBNP and NYHA - supporting it as a surrogate outcome in HF trials. 🚶‍♂️50m increase = 17%⬇️☠️ onlinelibrary.wiley.com/doi/10.1002/ej…

More data on #NTproBNP 🤓 In 🚺 who had gestational diabetes we found a strong link between ⬇️ NTproBNP and ⬆️ insulin resistance, which may explain part of the “BNP-obesity paradox’ and differences by race. link.springer.com/article/10.118… K.G. Jebsen Center for Cardiac Biomarkers @UniOslo_ME

Elevated #NatriureticPeptides and #troponins are strong predictors of #HF events, but ever wondered if these biomarkers predict worsening cardiac structure & function? We analyzed NT-proBNP, TnT and TnI in a/w serial echo in ~2000 👤 in #ARIC Just published in Circulation 🧵 /5

Gratulerer Karoline B. Rypdal MSc PhD med pris for beste forskningsformidling på 15-årsjubileet til @stiftkgj 🍾👏🏻 Følg kontoen hennes «Hjerteforsk» på Instagram!

Celebrating a great year for the K.G. Jebsen Center for Cardiac Biomarkers 🚀 UiO - Det medisinske fakultet @Ahus_no

Thrilled to announce that we have received ~2mill EUR from Helse- og omsorgsdep to conduct the STRONG@HOME trial at 7 sites in 🇳🇴🎉. Building on #STRONGHF, this trial will test efficacy and safety of rapid uptitration of #GDMT after HF hosp can be performed by digital follow-up 📲

#Editorial on Reddy et al. study Circulation: Standard NT-proBNP cutoffs miss HFpEF—especially in obesity. Reddy et al show BMI-adjusted thresholds boost diagnostic accuracy. Smarter HF dx is here. Nicholas Mills ahajournals.org/doi/full/10.11…

🎧 What an inspiring listen by Peder L. Myhre MD, PhD on tackling heart failure—from cutting-edge HF research to biomarker-driven care, global challenges of implementing digital health, and how Norway is reshaping participation in cardiology clinical trials. emjreviews.com/cardiology/pod…

This year’s summer seminar was one for the books with world class speakers Muthu Vaduganathan and Øyvind H Lie talking about the interaction between heart and kidney and how to interpret clinical trials! 🙏 thank you

Center leader Torbjørn Omland presenting the main results from the PRADA II at the ESC Congress🇨🇦🥳This multi center RCT tested the effect of ARNI in cancer patients receiving potential cardiotoxic treatment. The primary result was neutral.